IFNG and myeloid sarcoma: Further, after sustained exposure to non-toxic, low-dose IFNγ, induced pluripotent stem cells from peripheral blood mononuclear cells from progressive MS patients differentiated into OL lineage cells had reduced differentiation (Morales Pantoja et al., 2020; Starost et al., 2020).